Cita APA

Karamitopoulou, E., Zlobec, I., Gloor, B., Kondi-Pafiti, A., Lugli, A., & Perren, A. (2013). Loss of Raf-1 kinase inhibitor protein (RKIP) is strongly associated with high-grade tumor budding and correlates with an aggressive phenotype in pancreatic ductal adenocarcinoma (PDAC). BioMed Central.

Chicago Style Citation

Karamitopoulou, Eva, Inti Zlobec, Beat Gloor, Agathi Kondi-Pafiti, Alessandro Lugli, i Aurel Perren. Loss of Raf-1 Kinase Inhibitor Protein (RKIP) Is Strongly Associated With High-grade Tumor Budding and Correlates With an Aggressive Phenotype in Pancreatic Ductal Adenocarcinoma (PDAC). BioMed Central, 2013.

Cita MLA

Karamitopoulou, Eva, et al. Loss of Raf-1 Kinase Inhibitor Protein (RKIP) Is Strongly Associated With High-grade Tumor Budding and Correlates With an Aggressive Phenotype in Pancreatic Ductal Adenocarcinoma (PDAC). BioMed Central, 2013.